Ionetix



IONETIX is a leading molecular imaging diagnostics and therapeutics company focused on providing physicians and patients access to N-13 Ammonia. Used by a growing number of academic institutions, N-13 Ammonia is rapidly changing the standard of excellence for myocardial perfusion in cardiac PET imaging. By combining our expertise, experience, and cutting-edge infrastructure solution, IONETIX creates new pathways for bringing N-13 Ammonia into your practice. Our innovative dose service model eliminates the up-front expense and provides the support needed to launch a successful cardiac PET program, while helping to establish a brand-differentiating service that keeps patients close and drives referrals. For more information, visit: www.ionetix.com.

Product/Service Information
N-13 Ammonia provides:

  • Improved clinical accuracy
  • Superior image quality1
  • Less roll off at higher flows
  • Better extraction
  • Fewer correction factors

N-13 Ammonia paves the way to better diagnostics with a low positron range, excellent extraction and retention, high sensitivity and overall accuracy for detecting CAD.1 The result is better risk classification and overall patient management.
1. Fiechter et al., J Nucl Med 2012; 53: 1230-1234

 

TAKE YOUR CARDIAC IMAGING PROGRAM TO THE NEXT LEVEL

Create brand-leading cache for the institution by putting cutting-edge diagnostics in the hands of your providers. The advantages of the IONETIX approach are clear:

  • A reimbursable diagnostic offering benefits to referring physicians and their patients
  • A no-added-headcount approach to offering advanced diagnostic testing to patients
  • A strategic business opportunity that positions your physicians and institution on the cutting edge
     

A HANDS-OFF, WORRY-FREE SERVICE LINE OF DISTINCTION

IONETIX manages it all. We work with you to bring your cardiac program to the forefront of service line excellence.

  • Oversight of the entire construction and approvals process
  • No staff required — IONETIX employees handle daily operations related to radioisotope production
  • Ongoing clinical, marketing and reimbursement support
     

A ZERO CapEx MODEL FOR ACHIEVING STATE-OF-THE-ART CARDIAC IMAGING

Elevating your service line offering is surprisingly affordable when you partner with IONETIX.

  • IONETIX covers all CapEx costs associated with the entire project
  • You pay only for doses of N-13 Ammonia
  • On-site production of N-13 Ammonia creates the most reliable supply chain possible